FIELD: medicine.
SUBSTANCE: present invention relates to medicine, in particular to a method for treating a B-cell malignant disease, which is selected from the group consisting of non-Hodgkin's lymphoma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia.
EFFECT: implementation of the invention allows to increase the uptake of anti-CD20 antibodies by a tumour by increasing the level of CD20 by pre-administration of 177Lu monoclonal antibody HH1.
9 cl, 7 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL RADIOIMMUNOCONJUGATES AND THEIR APPLICATIONS | 2011 |
|
RU2560587C9 |
| NOVEL RADIOIMMUNOCONJUGATES AND USE THEREOF | 2011 |
|
RU2664475C1 |
| CHIMERIC THERAPEUTIC ANTI-CD-37 ANTIBODY HH1 | 2012 |
|
RU2658438C2 |
| COMPLEX CONTAINING A PSMA-TARGETING COMPOUND BOUND TO A LEAD OR THORIUM RADIONUCLIDE | 2018 |
|
RU2795398C2 |
| IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS | 2003 |
|
RU2335297C2 |
| CD37 BINDING MOLECULES AND IMMUNOCONJUGATES | 2011 |
|
RU2610662C9 |
| RADIOACTIVE METAL-LABELLED ANTI-CADHERIN ANTIBODY | 2011 |
|
RU2577125C2 |
| RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS | 2018 |
|
RU2811734C2 |
| RADIOPHARMACEUTICAL SOLUTIONS WITH PREFERRED PROPERTIES | 2016 |
|
RU2741794C2 |
| METHOD FOR PRODUCING RADIOIMMUNE PREPARATION FOR DIAGNOSING AND TREATING ONCOLOGICAL DISEASES | 2013 |
|
RU2537175C2 |
